Clinical Trials and the Importance of Patient Diversity

Jonathan Eilberg • Jan 21, 2023

To ensure clinical trial results are accurate, it is essential to recruit a diverse patient population with a wide range of backgrounds. That is why Trial AMPlify places such importance on recruiting a diverse group of participants for clinical trials. Recent advancements in clinical trial patient recruitment targeting have enabled researchers to tackle an ongoing hurdle in clinical studies -- subject diversity. 

Clinical trial patient diversity

With multiple pressing social needs, it is more important than ever for clinical trials to reflect the real-world population by recruiting a diverse pool of patients. At Trial AMPlify, we believe that the health needs of all individuals must be taken into account in order to create effective treatments for the general public. This is why our patient recruitment consulting services employ strategies to garner as many different types of subjects as possible.


First and foremost, greater diversity in clinical trial patient recruitment is key to creating treatments that are more tailored towards certain populations. By recruiting more diverse participants, trial researchers gain an understanding of how health differs across people with different genetic, cultural, and socio-economic backgrounds. Having a better understanding of these differences creates more targeted treatments that are more responsive to specific health needs.


A second vital effect of increasing trial diversity is improved accuracy in trial results. This is due to the fact that when groups of minority individuals are included in clinical trials, the patterns of results are more valid and more likely to be effective for everyone.


Studies have shown that when a clinical trial does not include a diverse patient population, the results of the study cannot be accurately applied to communities of people with different backgrounds. That is why it is so important for clinical trials to aim for balanced representation in the areas of gender, race, age and geography.


Trial AMPlify is a full-service patient recruitment and enrollment agency that helps biopharmaceutical companies quickly identify and target patients for clinical research and world-wide studies. We recognize the crucial role diversity plays in patient recruitment and we strive to ensure each trial has a broad, representative patient population that is reflective of the target treatment.


Contact Trial AMPlify for a FREE VIP Consultation. You'll be in good company.

Family of a clinical trial patient discussing a study
By Jon Eilberg 28 Apr, 2024
Trial AMPlify makes the case that a clinical trial is a family decision and that it may involve a spouse, sibling, or parent who is opposed to joining a study.
Clinical Trial Marketing
By Jonathan Eilberg 01 Jan, 2024
Clinical trial marketing is critical for building awareness, trust and credibility when announcing and promoting studies, but most sponsors skip this step.
Woman patient refusing to join a clinical trial
By Jonathan Eilberg 16 Dec, 2023
Trial AMPlify examines why people refuse to join clinical trials and the critical role patient recruitment firms play in increasing enrollment. Learn more
Clinical Trial Manager
By Jonathan Eilberg 04 Dec, 2023
Trial AMPlify examines why so many clinical trial patient recruitment campaigns fail and what can be done to help increase subject enrollment. Learn More
Patient Recruitment Agency
By Jonathan Eilberg 20 Nov, 2023
Trial AMPlify helps define what a patient recruitment agency does and the ways it can help sponsors and CRO's enroll qualified study subjects. Learn More
Clinical Trial Patient Recruitment Agency Team
14 Nov, 2023
Trial AMPlify presents a list of clinical trial patient recruitment terms for when a definition might escape you. Print the document for quick reference.
Patient Recruitment Website Traffic Graph
By Trial AMPlify 05 May, 2023
Trial AMPlify, a leader in clinical trial patient recruitment makes a case to help biotech’s launch studies more quickly in these tough financial times.
Clinical Trial diversity and how we get there
By Jonathan Eilberg 22 Mar, 2023
Trial AMPlify, a patient recruitment marketing agency based in Boston, relays ways US clinical trials can increase diverse patient enrollment.
Outsourcing Pharma Interview
23 Feb, 2023
Trial AMPlify is featured in latest issue of Outsourcing Pharma
Clinical Trial Abandonment
By Jonathan Eilberg 22 Feb, 2023
Trial AMPlify explores the reason why some patients leave clinical trials prematurely, and how this affects the outcome of the study data. Learn More.
More Posts
Share by: